The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(1-(4-hydroxyphenylsulfonyl)pyrrolidin-3-ylamino)nicotinonitrile ID: ALA4250825
PubChem CID: 145986287
Max Phase: Preclinical
Molecular Formula: C16H16N4O3S
Molecular Weight: 344.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(NC2CCN(S(=O)(=O)c3ccc(O)cc3)C2)nc1
Standard InChI: InChI=1S/C16H16N4O3S/c17-9-12-1-6-16(18-10-12)19-13-7-8-20(11-13)24(22,23)15-4-2-14(21)3-5-15/h1-6,10,13,21H,7-8,11H2,(H,18,19)
Standard InChI Key: GWEZTMRSBKWZRQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.2219 -6.5334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2208 -7.3529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9288 -7.7619 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6385 -7.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6357 -6.5298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9271 -6.1245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3469 -7.7599 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0544 -7.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8383 -7.5831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3055 -6.9126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8121 -6.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0401 -6.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1225 -6.8965 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5170 -6.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3329 -6.1699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7273 -5.4551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3047 -4.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4835 -4.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0928 -5.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5269 -7.5982 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9396 -6.8925 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5141 -6.1249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8036 -5.7162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6983 -4.0385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 8 1 0
10 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 2 0
13 21 2 0
1 22 1 0
22 23 3 0
17 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.40Molecular Weight (Monoisotopic): 344.0943AlogP: 1.53#Rotatable Bonds: 4Polar Surface Area: 106.32Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.29CX Basic pKa: 2.69CX LogP: 1.18CX LogD: 1.13Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.87Np Likeness Score: -2.11
References 1. Tawaraishi T, Sakauchi N, Hidaka K, Yoshikawa K, Okui T, Kuno H, Chisaki I, Aso K.. (2018) Identification of a novel series of potent and selective CCR6 inhibitors as biological probes., 28 (18): [PMID:30098865 ] [10.1016/j.bmcl.2018.07.042 ] 2. Tawaraishi, Taisuke T and 7 more authors. 2018-10-01 Identification of a novel series of potent and selective CCR6 inhibitors as biological probes. [PMID:30098865 ]